Brief: Aeterna Zentaris Reports Qtrly Net Loss Of $1.1 Million, Or $0.02 Loss Per Common Share

COSCIENS Biopharma

06/11/2020 13:39

Nov 6 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * AETERNA ZENTARIS INC - PIVOTAL PHASE 3 SAFETY AND EFFICACY
STUDY
AEZS-130-P02 ("STUDY P02") EXPECTED TO COMMENCE IN Q1 2021
    * AETERNA ZENTARIS INC - CASH RUNWAY TO FUND OPERATIONS AND
EXPECTED TO PROVIDE SIGNIFICANT OPTIONALITY FOR GROWTH
    * AETERNA ZENTARIS INC - BELIEVES IT HAS SUFFICIENT CAPITAL
TO
FUND ITS CURRENT OPERATIONS THROUGH 2023.
    * AETERNA ZENTARIS INC - QTRLY NET LOSS OF $1.1 MILLION, OR
$0.02
LOSS PER COMMON SHARE

Source text for Eikon:  ID:nGNX9qpJjc 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))